Ligand validation:1LA2

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1LA2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1LA2_NAD_C_902	38%	9%	0.204	0.906	2.59	1.91	9	11	2	0	100%	1
1LA2_NAD_B_901	21%	9%	0.24	0.848	2.62	1.82	9	9	1	0	100%	1
1LA2_NAD_A_900	17%	9%	0.266	0.847	2.61	1.81	9	10	2	0	100%	1
1LA2_NAD_D_903	16%	9%	0.258	0.826	2.59	1.83	11	9	2	0	100%	1
1P1H_NAD_B_660	80%	15%	0.12	0.97	2.51	1.26	10	6	3	0	100%	1
1P1I_NAD_A_650	55%	20%	0.185	0.954	2.17	1.24	8	9	2	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.